Cassava Sciences | PTIE - Trade Creditors


Cassava Sciences reported $39.19M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
Cara Therapeutics USD 3.22M 859K Dec/2025
Cassava Sciences USD 39.19M 2.46M Mar/2026
Eisai JPY 75.89B 9.6B Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
Geron USD 12.72M 1.46M Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Merck USD 3.86B 541M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Novavax USD 16.1M 8.48M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025